HIV protease inhibitors attenuate adherence of Candida albicans to epithelial cells in vitro

FEMS Immunology and Medical Microbiology

Volumn 31, Issue 1, 2001, Pages 65-71

  Bektić, Jasmin ^a   Lell, Claudia P ^a   Fuchs, Anita ^a   Stoiber, Heribert ^a   Speth, Cornelia ^a   Lass Flörl, Cornelia ^a   Borg Von Zepelin, Margarethe ^b   Dierich, Manfred P ^a   Würzner, Reinhard ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Adhesion; Candida; HIV; Protease inhibitor; Virulence

Indexed keywords

ASPARTIC PROTEINASE; INDINAVIR; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR;

ARTICLE; ATTENUATION; CANDIDA ALBICANS; CANDIDIASIS; CELL ADHESION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; ENZYME INHIBITION; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; PHAGOCYTOSIS; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL;

ASPARTIC ENDOPEPTIDASES; CANDIDA ALBICANS; CELL ADHESION; DOSE-RESPONSE RELATIONSHIP, DRUG; HELA CELLS; HIV PROTEASE INHIBITORS; HUMANS; INDINAVIR; NEUTROPHILS; PHAGOCYTOSIS; RITONAVIR; SAQUINAVIR;

EID: 0034890629     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(01)00242-5     Document Type: Article

References (33)

1. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection
2. The prevalence of oral lesions in HIV-infected homosexual and bisexual men: Three San Francisco epidemiological cohorts
3. Candida albicans isolates from HIV-infected and AIDS patients exhibit enhanced adherence to epithelial cells
4. Epidemiology of oral candidiasis in HIV-infected patients: Colonisation, infection, treatment, and emergence of fluconazole resistance
5. Relationship between clinical conditions and CD4 counts in HIV-infected persons in Pune, Maharashtra, India
6. Association of plasma levels of human immunodeficiency virus type 1 RNA and oropharyngeal Candida albicans colonisation
7. Candida albicans secreted aspartyl proteinases: Isoenzyme pattern is determined by cell type, and levels are determined by environmental factors
8. In vivo expression and localisation of Candida albicans secreted aspartyl proteinases during oral candidiasis in HIV-infected patients
9. Increased expression of Candida albicans secretory proteinase, a putative virulence factor, in isolates from human immunodeficiency virus-positive patients
10. Impact of new retroviral combination therapies in HIV infected patients in Switzerland - Prospective multicentre study
11. Frequency of oropharyngeal candidiasis in HIV-infected patients on protease inhibitor therapy
12. Impact of protease inhibitor therapy on HIV-related oropharyngeal candidiasis
13. Human polymorphonuclear leukocytes store large amounts of terminal complement components C7 and C6, which may be released on stimulation
14. Flow cytometric assay for combined measurement of phagocytosis and intracellular killing of Candida albicans
15. Human immunodeficiency virus potease inhibitors. From drug design to clinical studies
16. Modulation of experimental systemic murine candidosis by intravenous pepstatin A
17. Dissimilar attenuation of Candida albicans virulence properties by human immunodeficiency virus type 1 protease inhibitors
18. Human immunodeficiency virus type 1 protease inhibitor attenuates Candida albicans virulence properties in vitro
19. Effects of the human immunodeficiency virus (HIV) protease inhibitors on in vitro activities of secreted aspartyl proteinases of Candida albicans isolates from HIV-infected patients
20. In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors
21. Expression of extracellular acid proteinase by proteolytic Candida spp. during experimental infection of oral mucosa
22. Scanning electron microscopy of epidermal adherence and cavitation in murine candidiasis: A role for Candida acid proteinase
23. Mechanism of adherence of Candida albicans to cultured human epidermal keratinocytes
24. Role of aspartic proteases in disseminated Candida albicans infection in mice
25. Evidence that members of the secretory aspartyl proteinase gene family, in particular SAP2, are virulence factors for Candida vaginitis
26. HIV-protease inhibitors reduce cell adherence of Candida albicans strains by inhibition of yeast secreted aspartic proteases
27. The expression of the secreted aspartyl proteinases Sap4 to Sap6 from Candida albicans in murine macrophages
28. Germ tubes and proteinase activity contribute to virulence of Candida albicans in murine peritonitis
29. HIV-protease inhibitors
30. Does long-term itraconazole prophylaxis result in in vitro azole resistance in mucosal Candida albicans isolates from persons with advanced human immunodeficiency virus infection? The National Institute of Allergy and Infectious Disease Mycoses study group
31. Options for the management of mucosal candidiasis in patients with AIDS and HIV infection